Results 281 to 290 of about 7,259,671 (332)
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
TRPC3 and TRPC6: Multimodal Cation-Conducting Channels Regulating Cardiovascular Contractility and Remodeling. [PDF]
Numaga-Tomita T, Nishida M.
europepmc +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Lower limb muscle activation and biomechanics during single-leg hopping in different directions. [PDF]
Gu Y +6 more
europepmc +1 more source
M-Ras Distinct Activation Scenarios: A Mechanistic Outlook and Targeting
Xu, Liang
openalex +1 more source
Improving Clinical Patient Activation and Strengthening Health Outcomes: Findings from a Quasi-Experimental Study. [PDF]
Alsaad SM +7 more
europepmc +1 more source

